Mersana Therapeutics, Inc. (DELISTED) (MRSN:DL)
29.08
0.00 (0.00%)
USD |
NASDAQ |
Jan 15, 16:00
Mersana Therapeutics Total Assets (Annual): 144.66M for Dec. 31, 2024
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Cidara Therapeutics, Inc. | 215.58M |
| Day One Biopharmaceuticals, Inc. | 582.79M |
| Semler Scientific, Inc. | 243.04M |
| Cue Biopharma, Inc. | 32.19M |
| Scholar Rock Holding Corp. | 474.92M |